Heteroresistance to beta-lactam antibiotics may often be a stage in the progression to antibiotic resistance

Band, Victor I. and Weiss, David S. and Bollenbach, Tobias (2021) Heteroresistance to beta-lactam antibiotics may often be a stage in the progression to antibiotic resistance. PLOS Biology, 19 (7). e3001346. ISSN 1545-7885

[thumbnail of journal.pbio.3001346.pdf] Text
journal.pbio.3001346.pdf - Published Version

Download (1MB)

Abstract

Antibiotic resistance is a growing crisis that threatens many aspects of modern healthcare. Dogma is that resistance often develops due to acquisition of a resistance gene or mutation and that when this occurs, all the cells in the bacterial population are phenotypically resistant. In contrast, heteroresistance (HR) is a form of antibiotic resistance where only a subset of cells within a bacterial population are resistant to a given drug. These resistant cells can rapidly replicate in the presence of the antibiotic and cause treatment failures. If and how HR and resistance are related is unclear. Using carbapenem-resistant Enterobacterales (CRE), we provide evidence that HR to beta-lactams develops over years of antibiotic usage and that it is gradually supplanted by resistance. This suggests the possibility that HR may often develop before resistance and frequently be a stage in its progression, potentially representing a major shift in our understanding of the evolution of antibiotic resistance.

Item Type: Article
Subjects: Opene Prints > Biological Science
Depositing User: Managing Editor
Date Deposited: 13 Mar 2023 07:14
Last Modified: 17 May 2024 09:41
URI: http://geographical.go2journals.com/id/eprint/920

Actions (login required)

View Item
View Item